CN Stock MarketDetailed Quotes

000597 Northeast Pharmaceutical Group

Watchlist
  • 4.82
  • +0.01+0.21%
Market Closed May 17 15:00 CST
6.89BMarket Cap19.92P/E (TTM)

Northeast Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-17.58%1.94B
-6.42%8.24B
-2.52%6.4B
1.95%4.51B
0.02%2.35B
8.15%8.81B
7.60%6.57B
10.23%4.42B
16.49%2.35B
10.30%8.15B
Operating revenue
-17.58%1.94B
-6.42%8.24B
-2.52%6.4B
1.95%4.51B
0.02%2.35B
8.15%8.81B
7.60%6.57B
10.23%4.42B
16.49%2.35B
10.30%8.15B
Other operating revenue
----
-34.58%58.56M
----
7.31%29.36M
----
-9.32%89.5M
----
-33.83%27.36M
----
17.07%98.7M
Total operating cost
-18.64%1.82B
-9.14%7.66B
-3.92%6.03B
0.95%4.25B
-0.78%2.24B
5.83%8.44B
4.09%6.27B
7.69%4.21B
15.47%2.25B
10.11%7.97B
Operating cost
-9.10%1.2B
-9.06%4.89B
-6.16%3.78B
-5.23%2.57B
-8.33%1.32B
9.10%5.38B
8.49%4.03B
12.68%2.71B
20.38%1.44B
9.71%4.93B
Operating tax surcharges
-19.35%17.67M
-1.66%81.75M
0.64%61.88M
4.34%43.1M
6.72%21.91M
-0.88%83.13M
-5.84%61.49M
-1.86%41.31M
-4.39%20.53M
10.03%83.86M
Operating expense
-33.89%386.75M
-11.76%1.81B
-0.72%1.48B
12.38%1.11B
9.82%585.04M
1.72%2.05B
-0.10%1.49B
-0.42%986.54M
7.30%532.71M
15.56%2.02B
Administration expense
-33.67%204.15M
7.92%815.55M
11.19%708.52M
28.90%562.04M
32.06%307.76M
1.75%755.71M
1.13%637.2M
11.22%436.03M
12.62%233.05M
-0.24%742.69M
Financial expense
46.68%-5.84M
-478.84%-29.97M
-774.81%-50.08M
-1,152.19%-57.9M
-263.89%-10.95M
-93.13%7.91M
-106.54%-5.72M
-108.03%-4.62M
-66.07%6.68M
8.27%115.23M
-Interest expense (Financial expense)
-8.57%17.9M
-15.98%77.39M
-16.81%56.7M
-8.77%40.32M
-12.66%19.57M
-23.34%92.11M
-23.75%68.15M
-27.59%44.2M
-17.96%22.41M
-0.59%120.16M
-Interest Income (Financial expense)
32.17%-25.69M
-65.18%-155.08M
-82.97%-123.52M
-130.11%-100.93M
-91.35%-37.87M
-67.88%-93.88M
-142.07%-67.51M
-125.08%-43.86M
-103.05%-19.79M
4.29%-55.92M
Research and development
34.34%17.04M
-39.50%97.04M
-25.31%42.26M
-36.95%24.98M
-40.05%12.68M
92.18%160.39M
66.37%56.58M
87.90%39.63M
86.29%21.15M
12.51%83.46M
Credit Impairment Loss
138.62%257.5K
132.47%6.79M
137.78%2.96M
109.95%952.08K
83.26%-666.68K
-31.24%-20.9M
-453.54%-7.84M
-440.53%-9.57M
-109.24%-3.98M
-580.41%-15.92M
Asset Impairment Loss
-11.76%-37.67M
-30.54%-193.49M
-27.15%-138.66M
-57.42%-126.12M
-22.91%-33.7M
-55.39%-148.23M
-142.15%-109.06M
-108.92%-80.11M
-92.94%-27.42M
-16.42%-95.39M
Other net revenue
68.83%-3.51M
-124.99%-80.67M
8.14%-64.72M
-0.41%-64.47M
26.56%-11.26M
2,437.36%322.84M
-4,935.75%-70.46M
-500.50%-64.21M
-150.28%-15.33M
66.24%12.72M
Invest income
--2.27M
--8.61M
--8.29M
--7.62M
----
----
--0
----
----
--54.32M
Asset deal income
-90.86%6.65K
-99.96%172.21K
500.58%172.91K
328.89%173.92K
79.48%72.78K
12,641.67%419.3M
-101.96%-43.16K
1,263.60%40.55K
1,279.75%40.55K
-73.22%3.29M
Other revenue
37.26%31.62M
33.84%97.26M
34.49%62.51M
107.98%52.9M
43.71%23.04M
9.40%72.67M
18.51%46.48M
2.38%25.43M
60.52%16.03M
-10.23%66.42M
Operating profit
10.06%117.67M
-28.45%498.23M
37.80%313.74M
31.77%190.56M
26.22%106.92M
271.69%696.36M
188.73%227.67M
63.51%144.61M
35.43%84.71M
22.33%187.35M
Add:Non operating Income
-68.65%2.36M
-4.71%28.99M
-25.24%15.09M
-50.02%8.02M
260.63%7.54M
344.36%30.43M
436.46%20.18M
551.38%16.04M
317.60%2.09M
-52.17%6.85M
Less:Non operating expense
6,746.51%3.6M
-80.61%39.05M
-35.90%25.18M
376.06%4.53M
-93.75%52.53K
171.96%201.34M
44.57%39.28M
-90.81%950.9K
-91.61%839.93K
-2.11%74.03M
Total profit
1.78%116.43M
-7.09%488.17M
45.59%303.64M
21.51%194.05M
33.09%114.4M
337.27%525.44M
276.18%208.57M
98.24%159.7M
62.07%85.96M
30.84%120.16M
Less:Income tax cost
37.75%56.65M
-33.33%112.19M
-3.85%69.17M
20.38%49.22M
207.79%41.13M
580.72%168.28M
170.76%71.94M
131.72%40.88M
-4.46%13.36M
-69.48%24.72M
Net profit
-18.41%59.78M
5.27%375.98M
71.62%234.47M
21.90%144.83M
0.94%73.27M
274.22%357.16M
373.20%136.63M
88.85%118.81M
85.90%72.59M
781.47%95.44M
Net profit from continuing operation
-18.41%59.78M
5.27%375.98M
71.62%234.47M
21.90%144.83M
0.94%73.27M
274.22%357.16M
373.20%136.63M
88.85%118.81M
85.90%72.59M
781.47%95.44M
Less:Minority Profit
-33.40%2.15M
153.76%17.52M
73.10%14.69M
59.80%9.94M
-24.36%3.22M
292.55%6.9M
151.46%8.49M
146.05%6.22M
1,056.80%4.26M
-150.86%-3.59M
Net profit of parent company owners
-17.72%57.63M
2.34%358.46M
71.52%219.78M
19.80%134.89M
2.51%70.05M
253.69%350.25M
402.55%128.14M
86.46%112.59M
76.65%68.33M
707.93%99.03M
Earning per share
Basic earning per share
-18.37%0.04
0.00%0.25
63.15%0.1532
12.57%0.094
-3.92%0.049
257.14%0.25
396.83%0.0939
85.56%0.0835
75.86%0.051
600.00%0.07
Diluted earning per share
-18.37%0.04
0.00%0.25
63.15%0.1532
12.57%0.094
-3.92%0.049
257.14%0.25
396.83%0.0939
85.56%0.0835
75.86%0.051
600.00%0.07
Other composite income
135.84%66.13K
-69.04%921.94K
-63.85%1.42M
-11.33%1.62M
-42.26%-184.5K
619.62%2.98M
3,657.81%3.92M
971.61%1.82M
-200.73%-129.69K
57.48%-573.09K
Other composite income of parent company owners
134.51%66.47K
-69.13%919.41K
-63.98%1.42M
-11.62%1.62M
-46.92%-192.64K
619.62%2.98M
3,636.47%3.94M
968.07%1.83M
-200.87%-131.12K
57.61%-573.09K
Other composite income of minority owners
-104.23%-344.1
--2.53K
99.44%-77.36
82.84%-1.3K
470.47%8.14K
----
-1,403.55%-13.73K
-539.81%-7.6K
215.30%1.43K
----
Total composite income
-18.12%59.85M
4.66%376.9M
67.83%235.89M
21.39%146.45M
0.86%73.09M
279.62%360.13M
388.65%140.55M
92.39%120.64M
84.96%72.46M
900.75%94.87M
Total composite income of parent company owners
-17.40%57.7M
1.74%359.38M
67.48%221.2M
19.30%136.5M
2.43%69.86M
258.78%353.23M
420.26%132.07M
90.16%114.42M
75.72%68.2M
802.83%98.45M
Total composite income of minority owners
-33.58%2.15M
153.80%17.52M
73.38%14.69M
59.97%9.94M
-24.19%3.23M
292.55%6.9M
150.98%8.47M
145.59%6.21M
1,061.09%4.26M
-151.57%-3.59M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -17.58%1.94B-6.42%8.24B-2.52%6.4B1.95%4.51B0.02%2.35B8.15%8.81B7.60%6.57B10.23%4.42B16.49%2.35B10.30%8.15B
Operating revenue -17.58%1.94B-6.42%8.24B-2.52%6.4B1.95%4.51B0.02%2.35B8.15%8.81B7.60%6.57B10.23%4.42B16.49%2.35B10.30%8.15B
Other operating revenue -----34.58%58.56M----7.31%29.36M-----9.32%89.5M-----33.83%27.36M----17.07%98.7M
Total operating cost -18.64%1.82B-9.14%7.66B-3.92%6.03B0.95%4.25B-0.78%2.24B5.83%8.44B4.09%6.27B7.69%4.21B15.47%2.25B10.11%7.97B
Operating cost -9.10%1.2B-9.06%4.89B-6.16%3.78B-5.23%2.57B-8.33%1.32B9.10%5.38B8.49%4.03B12.68%2.71B20.38%1.44B9.71%4.93B
Operating tax surcharges -19.35%17.67M-1.66%81.75M0.64%61.88M4.34%43.1M6.72%21.91M-0.88%83.13M-5.84%61.49M-1.86%41.31M-4.39%20.53M10.03%83.86M
Operating expense -33.89%386.75M-11.76%1.81B-0.72%1.48B12.38%1.11B9.82%585.04M1.72%2.05B-0.10%1.49B-0.42%986.54M7.30%532.71M15.56%2.02B
Administration expense -33.67%204.15M7.92%815.55M11.19%708.52M28.90%562.04M32.06%307.76M1.75%755.71M1.13%637.2M11.22%436.03M12.62%233.05M-0.24%742.69M
Financial expense 46.68%-5.84M-478.84%-29.97M-774.81%-50.08M-1,152.19%-57.9M-263.89%-10.95M-93.13%7.91M-106.54%-5.72M-108.03%-4.62M-66.07%6.68M8.27%115.23M
-Interest expense (Financial expense) -8.57%17.9M-15.98%77.39M-16.81%56.7M-8.77%40.32M-12.66%19.57M-23.34%92.11M-23.75%68.15M-27.59%44.2M-17.96%22.41M-0.59%120.16M
-Interest Income (Financial expense) 32.17%-25.69M-65.18%-155.08M-82.97%-123.52M-130.11%-100.93M-91.35%-37.87M-67.88%-93.88M-142.07%-67.51M-125.08%-43.86M-103.05%-19.79M4.29%-55.92M
Research and development 34.34%17.04M-39.50%97.04M-25.31%42.26M-36.95%24.98M-40.05%12.68M92.18%160.39M66.37%56.58M87.90%39.63M86.29%21.15M12.51%83.46M
Credit Impairment Loss 138.62%257.5K132.47%6.79M137.78%2.96M109.95%952.08K83.26%-666.68K-31.24%-20.9M-453.54%-7.84M-440.53%-9.57M-109.24%-3.98M-580.41%-15.92M
Asset Impairment Loss -11.76%-37.67M-30.54%-193.49M-27.15%-138.66M-57.42%-126.12M-22.91%-33.7M-55.39%-148.23M-142.15%-109.06M-108.92%-80.11M-92.94%-27.42M-16.42%-95.39M
Other net revenue 68.83%-3.51M-124.99%-80.67M8.14%-64.72M-0.41%-64.47M26.56%-11.26M2,437.36%322.84M-4,935.75%-70.46M-500.50%-64.21M-150.28%-15.33M66.24%12.72M
Invest income --2.27M--8.61M--8.29M--7.62M----------0----------54.32M
Asset deal income -90.86%6.65K-99.96%172.21K500.58%172.91K328.89%173.92K79.48%72.78K12,641.67%419.3M-101.96%-43.16K1,263.60%40.55K1,279.75%40.55K-73.22%3.29M
Other revenue 37.26%31.62M33.84%97.26M34.49%62.51M107.98%52.9M43.71%23.04M9.40%72.67M18.51%46.48M2.38%25.43M60.52%16.03M-10.23%66.42M
Operating profit 10.06%117.67M-28.45%498.23M37.80%313.74M31.77%190.56M26.22%106.92M271.69%696.36M188.73%227.67M63.51%144.61M35.43%84.71M22.33%187.35M
Add:Non operating Income -68.65%2.36M-4.71%28.99M-25.24%15.09M-50.02%8.02M260.63%7.54M344.36%30.43M436.46%20.18M551.38%16.04M317.60%2.09M-52.17%6.85M
Less:Non operating expense 6,746.51%3.6M-80.61%39.05M-35.90%25.18M376.06%4.53M-93.75%52.53K171.96%201.34M44.57%39.28M-90.81%950.9K-91.61%839.93K-2.11%74.03M
Total profit 1.78%116.43M-7.09%488.17M45.59%303.64M21.51%194.05M33.09%114.4M337.27%525.44M276.18%208.57M98.24%159.7M62.07%85.96M30.84%120.16M
Less:Income tax cost 37.75%56.65M-33.33%112.19M-3.85%69.17M20.38%49.22M207.79%41.13M580.72%168.28M170.76%71.94M131.72%40.88M-4.46%13.36M-69.48%24.72M
Net profit -18.41%59.78M5.27%375.98M71.62%234.47M21.90%144.83M0.94%73.27M274.22%357.16M373.20%136.63M88.85%118.81M85.90%72.59M781.47%95.44M
Net profit from continuing operation -18.41%59.78M5.27%375.98M71.62%234.47M21.90%144.83M0.94%73.27M274.22%357.16M373.20%136.63M88.85%118.81M85.90%72.59M781.47%95.44M
Less:Minority Profit -33.40%2.15M153.76%17.52M73.10%14.69M59.80%9.94M-24.36%3.22M292.55%6.9M151.46%8.49M146.05%6.22M1,056.80%4.26M-150.86%-3.59M
Net profit of parent company owners -17.72%57.63M2.34%358.46M71.52%219.78M19.80%134.89M2.51%70.05M253.69%350.25M402.55%128.14M86.46%112.59M76.65%68.33M707.93%99.03M
Earning per share
Basic earning per share -18.37%0.040.00%0.2563.15%0.153212.57%0.094-3.92%0.049257.14%0.25396.83%0.093985.56%0.083575.86%0.051600.00%0.07
Diluted earning per share -18.37%0.040.00%0.2563.15%0.153212.57%0.094-3.92%0.049257.14%0.25396.83%0.093985.56%0.083575.86%0.051600.00%0.07
Other composite income 135.84%66.13K-69.04%921.94K-63.85%1.42M-11.33%1.62M-42.26%-184.5K619.62%2.98M3,657.81%3.92M971.61%1.82M-200.73%-129.69K57.48%-573.09K
Other composite income of parent company owners 134.51%66.47K-69.13%919.41K-63.98%1.42M-11.62%1.62M-46.92%-192.64K619.62%2.98M3,636.47%3.94M968.07%1.83M-200.87%-131.12K57.61%-573.09K
Other composite income of minority owners -104.23%-344.1--2.53K99.44%-77.3682.84%-1.3K470.47%8.14K-----1,403.55%-13.73K-539.81%-7.6K215.30%1.43K----
Total composite income -18.12%59.85M4.66%376.9M67.83%235.89M21.39%146.45M0.86%73.09M279.62%360.13M388.65%140.55M92.39%120.64M84.96%72.46M900.75%94.87M
Total composite income of parent company owners -17.40%57.7M1.74%359.38M67.48%221.2M19.30%136.5M2.43%69.86M258.78%353.23M420.26%132.07M90.16%114.42M75.72%68.2M802.83%98.45M
Total composite income of minority owners -33.58%2.15M153.80%17.52M73.38%14.69M59.97%9.94M-24.19%3.23M292.55%6.9M150.98%8.47M145.59%6.21M1,061.09%4.26M-151.57%-3.59M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg